CXL OPHTHALMICS, INC. — Form D
CXL OPHTHALMICS, INC. of SHERBORN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-12. The offering totals $50.3M, of which $26.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-10-12
- Form: D
- Accession: 0001949734-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $50.3M
- Amount sold: $26.4M
- Remaining: $23.9M
- Investors: 67
- Date of first sale: 2022-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461458
Issuer
- Name: CXL OPHTHALMICS, INC.
- CIK: 0001949734
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 161 FOREST STREET, SHERBORN, MA, 01770
- Phone: 339-234-6020
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Curt LaBelle | Director | Cambridge, MA |
| SUSAN MACDONALD | Director | SHERBORN, MA |
| MARC ODRICH | Director | Charlottesville, VA |
| Jonathan Talamo | Director | Brooklyn Park, MN |
| Michael Webb | Director | Wheaton, IL |
| EDWARD PARSONS | Executive Officer | SHERBORN, MA |
| Michael Webb | Executive Officer | Wheaton, IL |
More